Lord, Abbett & Co
ELGX

Lord, Abbett & Co’s Endologix Inc ELGX Stock Holding History

Lord, Abbett & Co’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-38,174
Closed -$4.89M – 989
2016
Q3 		$4.89M Buy
38,174
+501
+1% +$64.1K 0.01% 740
2016
Q2 		$4.69M Buy
+37,673
New +$4.33M 0.01% 726
2016
Q1 		– Sell
-208,010
Closed -$20.6M – 989
2015
Q4 		$20.6M Buy
208,010
+133,148
+178% +$14.3M 0.06% 424
2015
Q3 		$9.18M Sell
74,862
-143,428
-66% -$19.5M 0.03% 611
2015
Q2 		$33.5M Buy
+218,290
New +$36M 0.09% 361
2014
Q4 		– Sell
-8,770
Closed -$930K – 1020
2014
Q3 		$930K Buy
+8,770
New +$1.22M ﹤0.01% 935
2014
Q1 		– Sell
-278,497
Closed -$48.6M – 1113
2013
Q4 		$48.6M Buy
278,497
+55,078
+25% +$9.46M 0.11% 270
2013
Q3 		$36M Buy
223,419
+142,808
+177% +$22.5M 0.08% 358
2013
Q2 		$10.7M Buy
+80,611
New +$11.4M 0.02% 617

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Lord, Abbett & Co's ELGX Position: Q4 2016 in Review

Lord, Abbett & Co sold out of Endologix Inc (ELGX) in Q4 2016, closing a stake of 38,174 shares — an estimated $4.89M sold.

Lord, Abbett & Co first reported a position in ELGX in Q2 2013 and held it in 9 quarters. The position peaked at $48.6M in Q4 2013. 140 funds tracked by Wall St. Rank hold ELGX as of Q4 2016.

  • Lord, Abbett & Co reported no remaining Endologix Inc position as of Q4 2016 after selling out during the quarter.
  • Lord, Abbett & Co sold 38,174 Endologix Inc shares in Q4 2016, an estimated $4.89M.
  • Lord, Abbett & Co first reported a position in Endologix Inc in Q2 2013 and held it in 9 quarters.
  • Lord, Abbett & Co's Endologix Inc position peaked at $48.6M in Q4 2013.
  • 140 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2016.

Based on Lord, Abbett & Co's 13F filing for Q4 2016, filed 14 Feb 2017.